文献速递牙体牙髓病

阿替卡因三种注射法对下颌第一磨牙症状性不可逆性牙髓炎的麻醉成功率:CONSORT随机双盲临床试验

Success Rate of 3 Injection Methods with Articaine for Mandibular First Molars with Symptomatic Irreversible Pulpitis: A CONSORT Randomized Double-blind Clinical Trial.
PubMed 文献 · J Endod · 2018-08-31

结果显示下牙槽神经阻滞联合牙周膜注射成功率75%,联合颊侧浸润为65.6%,单纯下牙槽神经阻滞仅28.1%。结论认为联合补充注射可提高成功率,但无一种方法达到完全成功。

要点

  • 单纯下牙槽神经阻滞麻醉成功率仅28.1%,补充注射可显著提高成功率。
  • 下牙槽神经阻滞联合牙周膜注射成功率75%,为三种方法中最高。
  • 下牙槽神经阻滞联合颊侧浸润成功率65.6%,均优于单纯阻滞。

核心结论

  • 在症状性不可逆性牙髓炎下颌第一磨牙中,下牙槽神经阻滞联合牙周膜注射或颊侧浸润可提高阿替卡因麻醉成功率,但无一种方法完全成功。

研究设计与样本

  • 三组分别为单纯下牙槽神经阻滞、阻滞后颊侧浸润、阻滞后牙周膜注射,均使用4%阿替卡因含1:100,000肾上腺素。

主要发现

  • 下牙槽神经阻滞联合牙周膜注射成功率75%,联合颊侧浸润成功率65.6%,单纯下牙槽神经阻滞成功率28.1%。
  • 成功定义为开髓或初始器械操作时视觉模拟量表记录无痛或轻度疼痛。

关键数值与推荐

  • 成功率:阻滞+牙周膜注射75%,阻滞+颊侧浸润65.6%,单纯阻滞28.1%。
  • 麻醉溶液为4%阿替卡因含1:100,000肾上腺素。
  • 阻滞后15分钟出现唇麻木后行补充注射,阻滞后20分钟开始牙髓治疗。
  • 统计采用卡方检验和Mann-Whitney U检验,P < .05为显著。

临床怎么用

  • 对下颌第一磨牙症状性不可逆性牙髓炎,单纯下牙槽神经阻滞成功率低,建议联合牙周膜或颊侧浸润补充注射。
  • 补充注射应在阻滞后唇麻木确认后(约15分钟)进行,阻滞后20分钟再开始治疗。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Previous studies have reported that it is difficult to obtain proper anesthesia in mandibular molars with symptomatic irreversible pulpitis, and supplemental injections are usually unavoidable. The aim of the present study was to determine the anesthetic efficacy of articaine in mandibular first molars with symptomatic irreversible pulpitis with 3 injection methods: an inferior alveolar nerve block (IANB), an IANB with an intraligamentary injection, and an IANB with buccal infiltration before initiating the endodontic treatment. METHODS: Ninety-six patients (54 women and 42 men) with a diagnosis of symptomatic irreversible pulpitis in mandibular first molars were selected and randomly assigned into 3 groups (n = 32) according to the injection method as follows: group 1, a conventional IANB injection; group 2, an IANB injection, and after profound lip numbness after the IANB (after 15 minutes), buccal infiltration was administered; and group 3, an IANB injection, and after profound lip numbness after the IANB (after 15 minutes), an intraligamentary injection was performed, and after 20 minutes from the IANB, the endodontic treatment was initiated. The anesthetic solution was articaine 4% with 1:100,000 epinephrine. Success was defined as no or mild pain on the basis of the visual analog scale recording upon access cavity preparation or initial instrumentation. Data were statistically analyzed using the chi-square and Mann-Whitney U tests, and P < .05 was set as significant. RESULTS: The success rate for IANBs with an intraligamentary injection was 75%, and for IANBs with a buccal injection, it was 65.6%. For IANBs alone, the success rate was 28.1%. CONCLUSIONS: Considering the limitations of the present study, in can be concluded that the success rate of IANBs increased with intraligamentary injections and buccal infiltrations with articaine that were performed before initiating treatment. Also, none of the injection methods showed complete success in anesthesia in all patients.

来源:J Endod,查看原文。版权归原作者所有。

引用

  1. Shahi S, Rahimi S, Yavari HR, et al. Success Rate of 3 Injection Methods with Articaine for Mandibular First Molars with Symptomatic Irreversible Pulpitis: A CONSORT Randomized Double-blind Clinical Trial. J Endod. 2018. PMID: 30174101. doi:10.1016/j.joen.2018.07.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。